RNA phosphate backbone

The RNA phosphate backbone is the repeating structural framework of ribonucleic acid, composed of alternating ribose sugar units and phosphate groups linked by 3'-5' phosphodiester bonds [1]. This polyanionic scaffold provides the necessary structural stability and orientation for the nitrogenous bases to participate in genetic coding, protein synthesis, and ribozyme-mediated catalysis [2]. While not a specific protein receptor, the phosphate backbone serves as a primary site for electrostatic interactions with metal cations and various small-molecule drugs, such as aminoglycoside antibiotics, which bind to the ribosomal RNA backbone to disrupt bacterial translation [3]. In the development of antisense oligonucleotides (ASOs) and siRNA therapies, the backbone itself is frequently the subject of chemical modification—such as the introduction of phosphorothioate linkages—to enhance resistance to nuclease degradation and improve therapeutic half-life [4]. Consequently, the RNA backbone is a fundamental element in both the structural biology of the cell and the design of modern nucleic acid-based therapeutics targeting viral and genetic diseases [5]. [1] Berg JM, et al. Biochemistry. 5th edition. [2] Nelson DL, Cox MM. Lehninger Principles of Biochemistry. [3] Vicens Q, Westhof E. Science, 2001. [4] Khvorova A, Watts JK. Nature Biotechnology, 2017. [5] Hermann T. Angewandte Chemie, 2000.

Other names

Phosphodiester backboneRNA sugar-phosphate backboneRibonucleic acid backbone3'-5' phosphodiester linkage

Drugs interact with the RNA phosphate backbone through electrostatic binding between positively charged drug moieties and negatively charged phosphate groups, as well as through hydrogen bonding with the ribose hydroxyl groups to stabilize drug-RNA complexes and interfere with biological processes like translation or splicing.